source
- Eli Lilly partners with AI startup Profluent to develop next-generation gene editorsEli Lilly announced a collaboration with AI-focused biotech Profluent to create advanced gene-editing tools that could insert whole genes into patients. The partnership is intended to move beyond…
- Novartis CEO says Trump’s drug pricing plan creates a very difficult situation for makers and patientsNovartis chief executive Vas Narasimhan warned that the United States drug‑pricing policy under President Trump presents a "very difficult situation" for both drugmakers and patients. He said the…